Cholesterol Conversations
✓

Cholesterol Conversations

ABOUT THIS PODCAST 🔗

Statin therapy is the first-line pharmacologic treatment for lowering low-density lipoprotein cholesterol (LDL-C) and reducing atherosclerotic cardiovascular disease (ASCVD) risk. However, evidence-based and guideline-recommended therapies continue to be underutilized — even among the highest risk patients. More education is needed to address gaps in ASCVD care, particularly among patients who cannot reach their LDL-C goals with statin therapy alone.
VLN is pleased to launch Cholesterol Conversations, a limited-series podcast discussing the latest guidance on ASCVD management and available treatment options for optimal LDL-C lowering. New data on the efficacy of novel agents and combination therapy is also highlighted.
Medicine
Education
Medicine
Health & Fitness
Hosts:
Update frequency:
every 439 days
Average audio length:
24 minutes
Guest interviews
Has sponsors
English
United States
4 episodes
since Feb. 21, 2023
episodic
Use API to fetch this podcast in JSON

IN THIS PODCAST 🔗

Edit these tags

LATEST EPISODE 🔗

Now What? Putting the 2026 Dyslipidemia Guidelines into Practice

Now What? Putting the 2026 Dyslipidemia Guidelines into Practice

Your patient's LDL-C is still above goal. What should you do next? Dr. Heather Johnson and Professor Viet Le put the 2026 dyslipidemia guidelines into clinical context and discuss how to use PREVENT-ASCVD, lipoprotein(a), and other risk markers to tailor treatment, set LDL goals, and determine when…
00:24:48
SHARE
SAVE

SEARCH PAST EPISODES

Search past episodes of Cholesterol Conversations.
Embed this search bar to your website

PREVIOUS EPISODES

Mastering LDL Management in 2025

Mastering LDL Management in 2025

· transcript
In this episode of Cholesterol Conversations, host Dr. Heather Johnson, Director of Preventive Cardiology for Women's Services at the Christine E. Lynn Women's Health & Wellness Institute of Baptist Health South Florida, sits down with Dr. Viet T. Le, Associate Professor of Research and Co-Dire…
00:29:44
SHARE
SAVE
How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals

How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals

In this episode of Cholesterol Conversations, Drs. Marc Bonaca, Pam Taub, and Heather Johnson discuss how multiagent therapy can improve the provision of care in the real world. Covered topics include new data from the 2023 ACC Scientific Sessions on the efficacy of novel agents and the role of com…
00:19:16
SHARE
SAVE
ASCVD Management: Making the Case for Nonstatin Therapies

ASCVD Management: Making the Case for Nonstatin Therapies

In this episode of Cholesterol Conversations, join Drs. Neha Pagidipati, Christie Ballantyne, and Gregory Piazza for a roundtable discussion that addresses recent guidance on ASCVD management, current gaps in ASCVD care, patient barriers to LDL-C lowering, and nonstatin therapies to consider for pa…
00:21:25
SHARE
SAVE
You have seen all episodes of this podcast
Disclaimer: The podcast and artwork embedded on this page are from Vasculearn Network, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
PODCAST SEARCH ENGINE
You can use our website to search 3,822,650 podcasts and 195,582,889 episodes by people, places, or topics.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of giants.  ‐ Isaac "Llamacorn" Newton

RECOMMENDATIONS

Use API to fetch this podcast